Back to Awarded Treatment Trials
Awarded Trial: 03T-324
Grant ID
03T-324
Illness
Schizophrenia
Primary Drug/Intervention
Pravastatin
Primary Dosage
10mg/d
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Brar
Sample Size
60
Duration of Study Period for Each Subject
26 weeks
Outcome Measurements
PANSS, CDSS, RBANS, GAF
Results
Fifty-nine patients were randomized to receive adjunctive pravastatin or placebo. There were no significant differences between groups on measures of psychiatric symptoms or on cognitive tests.
Publication
N/A
Link
N/A
PI Name
Jaspreet Brar
Degree
MD
Center
CCS, Western Psychiatric Institute and Clinic
Institution
University of Pittsburgh
Address
3501 Forbes Avenue, Room 349
City or Town
Pittsburgh
State or Province
PA
Zip or Postal Code
15213
Country
USA
Email Address
brarjs@msx.upmc.edu